ICD-10 code G26: Extrapyramidal and movement disorders guide

Key Takeaways

G26 is a billable ICD-10-CM code for extrapyramidal and movement disorders caused by an underlying disease classified elsewhere in the code set.

G26 is a manifestation code: the underlying etiology (e.g., Wilson’s disease, kernicterus) must always be sequenced first on the claim.

Never use G26 for drug-induced extrapyramidal reactions; those map to G21.1 or G25.70/G25.71 depending on the clinical presentation.

Pabau’s claims management software supports accurate multi-code sequencing to reduce denials on complex neurological claims.

ICD-10 code G26 is a billable ICD-10-CM code for extrapyramidal and movement disorders that occur as a manifestation of an underlying disease classified elsewhere. It carries a mandatory “Code first” instruction: the ICD-10-CM Official Guidelines for Coding and Reporting require the underlying etiology to be sequenced ahead of G26 on every claim.

Coders sometimes assign G26 correctly but sequence it before the underlying disease, which violates the etiology-manifestation convention and triggers an automatic denial. This guide covers the G26 definition, sequencing rules, related codes, and documentation requirements practices need to bill accurately.

G26 sits at the end of the G20-G26 extrapyramidal and movement disorders block, the catch-all for movement disorder manifestations that arise from conditions classified in other chapters.

ICD-10 code G26: Definition and clinical description

ICD-10 code G26 describes extrapyramidal and movement disorders that occur as a direct consequence of an underlying disease documented elsewhere in ICD-10-CM. The term “extrapyramidal” refers to the neural pathways outside the pyramidal (corticospinal) tract that regulate involuntary motor control, coordination, and muscle tone.

Dysfunction in these pathways produces clinical presentations including tremor, rigidity, dystonia, bradykinesia, chorea, and athetosis.

What separates G26 from other movement disorder codes is its secondary nature. The extrapyramidal symptoms are a manifestation of a primary condition, not a standalone diagnosis. That underlying condition is what drives ICD-10-CM to require etiology-first sequencing through the “Code first” instruction attached to G26.

According to the WHO ICD-10 classification, G26 falls under Chapter VI: Diseases of the Nervous System (G00-G99), within the G20-G26 block covering extrapyramidal and movement disorders.

In the U.S., the CDC/NCHS ICD-10-CM tabular list carries this code forward with the same structure and full “Code first” instruction. G26 is a billable, specific code valid for reimbursement purposes in the current fiscal year.

Common underlying conditions that trigger G26

G26 applies when the movement disorder is a direct manifestation of one of the following categories of underlying disease:

• Metabolic/inherited disorders: Wilson’s disease/hepatolenticular degeneration (E83.01), an ICD-10-CM Code first example for G26, causes copper accumulation that produces dystonia, tremor, and parkinsonism
• Perinatal conditions: Kernicterus (P57.-), the other ICD-10-CM Code first example for G26, causes choreoathetoid movement patterns from bilirubin-induced brain damage in newborns
• Neurodegenerative diseases: Huntington’s disease (G10) causes chorea and other movement abnormalities, though chorea is inherent to G10 itself and is not normally double-coded with G26; chorea from a different underlying cause indexes to G25.5
• Infectious and post-infectious conditions: Certain encephalitides and Creutzfeldt-Jakob disease (A81.0-) can present with extrapyramidal features
• Autoimmune and inflammatory conditions: Systemic lupus erythematosus (M32.-) and antiphospholipid syndrome with neurological involvement
• Paraneoplastic syndromes: Movement disorders occurring as remote effects of malignancy

The unifying principle is that the movement disorder cannot be explained independently; it exists because the underlying disease is active.

G26 quick reference

The table below summarizes the key coding attributes for G26 at a glance.

G26 coding guidelines: Sequencing and Code first rules

The single most important rule for ICD-10 code G26 is the etiology-manifestation sequencing convention. When a condition has both a root cause (etiology) and a body-system consequence (manifestation), ICD-10-CM requires the etiology code to appear first in the diagnostic sequence. G26 carries an explicit “Code first” instruction in the tabular list, which makes this sequencing mandatory, not optional.

Incorrect claim: G26, E83.01 (Wilson’s disease coded second). Correct claim: E83.01, G26 (Wilson’s disease coded first as the etiology). A payer receiving a claim with G26 as the principal diagnosis on a claim where an underlying metabolic or neurodegenerative disease is the reason for the encounter will likely reject or query the claim.

How the etiology-manifestation convention works

The CMS ICD-10-CM Official Guidelines for Coding and Reporting describe the etiology-manifestation convention as follows: certain conditions have both an underlying etiology and multiple body-system manifestations. The sequencing rule directs coders to list the etiology first and the manifestation code second. Two indicators signal this relationship in the tabular list:

• “Code first” note on G26: instructs the coder to sequence the underlying condition before assigning G26
• “In diseases classified elsewhere” in the code title: signals that G26 is always a secondary code and cannot stand alone as a principal diagnosis without an etiology code

Both indicators appear on G26. Coders familiar with G59’s mononeuropathy-in-diseases-classified-elsewhere structure will recognize this as the same etiology-manifestation pattern used throughout Chapter G.

G26 as principal vs. additional diagnosis

G26 cannot be used as a principal diagnosis. The “in diseases classified elsewhere” qualifier in the code title and the “Code first” instruction both prohibit this. G26 functions exclusively as an additional (secondary) diagnosis code, assigned after the underlying etiology.

The only scenario where G26 appears alone on a claim is when billing for a visit focused solely on managing the movement disorder symptoms, and even then the underlying etiology code must still lead the sequence. Claims management software that supports multi-code sequencing validation helps prevent this sequencing error before submission.

Related codes and differential coding

G26 is easily confused with several adjacent codes in the G20-G26 block. Selecting the wrong code or using G26 when a more specific code exists leads to claim inaccuracies and audit exposure. The table below covers the most commonly confused alternatives.

The critical distinction between G26 and the G25 drug-induced codes is etiology. G26 is reserved for movement disorders secondary to a systemic or neurological disease. Drug-induced extrapyramidal effects belong in G21.1, G25.70, or G25.71, depending on the clinical presentation, with an additional T-code identifying the responsible drug.

Mixing these up creates a medical necessity mismatch, since the CPT or HCPCS codes billed must match the diagnosis actually documented. For a comparable Chapter G manifestation code with its own sequencing convention, see ICD-10 code G89.0 (central pain syndrome), which is likewise usually sequenced after the underlying diagnosis.

Reduce denials on complex neurological claims

Pabau's built-in claims management tools support multi-code sequencing validation so your team catches etiology-manifestation errors before they reach the payer. Book a demo to see how it works in a neurology or psychiatry workflow.

Book a demo

Documentation requirements for G26

Accurate documentation is the foundation for defensible G26 coding. A payer or auditor reviewing a claim with G26 will look for evidence in the clinical record that both the underlying disease and the resultant movement disorder are active and clinically significant at the time of the encounter.

What the record must establish

The medical record supporting a G26 claim needs to address four areas:

1. Confirmed underlying diagnosis: The etiology code must be supported by the record. A diagnosis of Wilson’s disease, kernicterus, Huntington’s disease, or another qualifying condition should appear in the problem list, prior visit notes, or current encounter documentation.
2. Active extrapyramidal or movement symptoms: The record should describe the specific motor symptoms observed or reported, such as dystonia, tremor, bradykinesia, chorea, or rigidity. Vague terms like “movement problems” do not support a specific neurological diagnosis code.
3. Clinical link between the underlying disease and the movement disorder: The provider’s documentation should establish that the movement disorder is a consequence of the underlying condition. A statement such as “extrapyramidal symptoms consistent with Wilson’s disease-related neurological involvement” supports the G26 code.
4. Encounter relevance: Both conditions must be clinically relevant to the encounter. If the visit is for unrelated reasons and the movement disorder is mentioned incidentally without being managed, G26 may not meet the threshold for secondary diagnosis reporting per the UHDDS definition.

Using AI-assisted clinical documentation tools can help providers capture the neurological detail and clinical linkage language that makes these records audit-ready.

Standardized digital intake and assessment forms for movement disorder evaluations also ensure consistent data capture across encounters, and a structured brain health assessment template can help standardize intake for these visits.

Excludes notes and coding boundaries

G26 has no Type 1 Excludes notes that would prohibit its use with other Chapter G codes when both conditions are genuinely present and documented. However, coders should review the tabular list entry carefully.

Drug-induced movement disorders carry their own dedicated codes (G21.1, G25.7x) and should not be swept into G26 simply because an underlying disease is also present. If a patient with Wilson’s disease is also taking an antipsychotic that is causing tardive dyskinesia, the drug-induced code (G25.71) and the underlying disease code apply separately from G26.

Billing guidance and common CPT codes

G26 is a diagnosis code, not a procedure code. It supports medical necessity for the CPT or HCPCS codes billed for the services rendered during the encounter. The CPT codes most commonly paired with G26 depend on the care setting and encounter type.

CPT codes commonly billed alongside G26

• 99202-99215 (Office/Outpatient E&M): The most frequently billed service category. Level selection depends on total time or medical decision-making complexity (see CPT code 99213 for established-patient visit criteria). Movement disorder assessments in the context of Wilson’s disease or Huntington’s typically support moderate to high complexity MDM.
• 99221-99223 (Initial hospital care) / 99231-99233 (Subsequent hospital care): For inpatient management of acute neurological deterioration with extrapyramidal features.
• 96110 (Developmental screening): Limited to pediatric-onset G26 presentations, such as kernicterus-related movement disorders identified in an infant or child during a developmental screening. It is not a typical CPT pairing for adult-onset G26 claims.
• 95923 / 95924 (Autonomic function testing): May accompany G26 in cases where autonomic dysfunction co-exists with the movement disorder.
• 90837 / 90832 (Psychotherapy): Can appear on the same claim when behavioral or psychiatric comorbidities are managed alongside the movement disorder, though these must be separately documented.

Payers including Medicare and Medicaid require medical necessity linkage between the diagnosis code and each CPT billed. The AAPC Codify ICD-10-CM lookup provides crosswalk data showing which CPT codes are commonly paired with G26 in real-world claims, useful for building payer-specific billing templates.

For practices managing neurology billing at scale, psychiatry and neurology practice software with integrated practice management capabilities reduces the manual burden of tracking code pairings across encounter types.

Payer-specific considerations

No universal reimbursement rate applies to G26 directly because it is a diagnosis code; reimbursement is determined by the CPT codes billed. Payer coverage policies for the underlying conditions associated with G26 vary, and some payers require prior authorization for specialist neurology services when the diagnosis involves a rare metabolic disorder such as Wilson’s disease.

Verify coverage policies before scheduling high-cost diagnostic procedures. The CMS and CDC/NCHS ICD-10-CM resources linked earlier in this guide provide the official tabular list and index for confirming current code status and any attached instructions.

Conclusion

Extrapyramidal and movement disorder claims involving G26 fail most often because of sequencing, not code selection. When the underlying disease is coded first and the documentation establishes the clinical link to the movement disorder, G26 performs exactly as ICD-10-CM intends it to: as a precise secondary code that captures the full diagnostic picture.

Pabau’s claims management software supports the multi-code sequencing workflows neurological practices need, reducing denials before they reach the payer. To see how Pabau handles complex diagnostic coding in a live environment, book a demo.

Continue your research

Need structured tools for neurology documentation? Pabau’s AI medical scribe helps clinicians capture detailed neurological findings and clinical linkage language that supports complex ICD-10 claims.

Managing movement disorder patients across multiple visits? Pabau’s client record tools maintain a longitudinal view of diagnoses, etiology codes, and treatment history for each patient.

Looking for psychiatry and neurology-specific practice software? Pabau’s psychiatry EMR is built for practices managing complex, multi-code neurological and psychiatric diagnoses.

Want to reduce HIPAA risk in your documentation workflows? HIPAA-compliant practice software guidance covers the data handling requirements relevant to neurological patient records.

Frequently asked questions